|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Behavior disorder |
|
Depression |
|
Psychosis |
| |
|
|
SIDE EFFECTS:
|
|
agranulocytosis |
|
akathisia |
|
aplastic anemia |
|
blurred vision |
|
cholestasis |
|
constipation |
|
contact dermatitis |
|
corneal opacification |
|
diaphoresis |
|
dizziness |
|
drowsiness |
|
dystonic reaction |
|
ejaculation dysfunction |
|
eosinophilia |
|
galactorrhea |
|
headache |
|
hyperprolactinemia |
|
hypertension |
|
hyperthermia |
|
hypotension |
|
hypothermia |
|
ileus |
|
impotence |
|
insomnia |
|
jaundice |
|
leukocytosis |
|
leukopenia |
|
libido decrease |
|
mastalgia |
|
menstrual irregularity |
|
mydriasis |
|
neuroleptic malignant syndrome |
|
orthostatic hypotension |
|
pancytopenia |
|
photosensitivity |
|
priapism |
|
pseudoparkinsonism |
|
QT prolongation |
|
retinopathy |
|
seizures |
|
sinus tachycardia |
|
skin hyperpigmentation |
|
tardive dyskinesia |
|
thrombocytopenia |
|
torsade de pointes |
|
urinary retention |
|
ventricular tachycardia |
|
visual impairment |
|
weight gain |
|
withdrawal |
|
xerostomia |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
abrupt discontinuation |
|
accidental exposure |
|
ambient temperature increase |
|
angina |
|
anticholinergic medications |
|
bone marrow suppression |
|
breast cancer |
|
breast-feeding |
|
cardiac disease |
|
chemotherapy |
|
children |
|
closed-angle glaucoma |
|
dehydration |
|
dental work |
|
driving or operating machinery |
|
elderly |
|
fever |
|
GI obstruction |
|
glaucoma |
|
hematological disease |
|
hepatic disease |
|
hypocalcemia |
|
hypotension |
|
hypothermia |
|
hypovolemia |
|
ileus |
|
infants |
|
infection |
|
infertility |
|
intracranial mass |
|
labor |
|
ocular disease |
|
Parkinson's disease |
|
pregnancy |
|
prostatic hypertrophy |
|
pulmonary disease |
|
radiographic contrast administration |
|
renal failure |
|
seizure disorder |
|
seizures |
|
suicidal ideation |
|
sunlight (UV) exposure |
|
surgery |
|
tardive dyskinesia |
|
tobacco smoking |
|
urinary retention |
|
|
ADULT DOSE:
|
|
Psychotic disorders-
Initial: Oral, 50 to 100 mg (hydrochloride) one to three times per day, the dosage being adjusted gradually as needed and tolerated .
Maintenance: Oral, 50 to 200 mg (hydrochloride) two to four times per day .
Sedation-
Initial: Oral, 25 mg (hydrochloride) three times per day, the dosage being adjusted gradually as needed and tolerated .
Maintenance: Oral, 10 to 50 mg (hydrochloride) two to four times per day .
Note: Geriatric, emaciated, or debilitated patients usually require a lower initial dose and more gradual dosage titration than do younger and healthier patients . |
|
MAXIMUM ADULT DOSE:
|
|
Psychotic disorders-
800 mg (hydrochloride) per day .
Note: Dosages greater than 300 mg (hydrochloride) per day should be used only in severe neuropsychiatric conditions .
Sedation-
200 mg (hydrochloride) per day . |
|
PEDIATRIC DOSE:
|
|
Psychotic disorders-
Children up to 2 years of age: Dosage has not been established.
Children 2 to 12 years of age: Oral, initially 10 to 25 mg (hydrochloride) two or three times per day, the dosage being adjusted gradually as needed and tolerated ; the usual dosage range is 250 mcg (0.25 mg) to 3 mg per kg of body weight or 7.5 mg per square meter of body surface area four times per day.
Children 12 years of age and older: See Usual adult and adolescent dose . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|